Therefore, if clients were to switch manufacturers, it would require establishing a new cell line that ... sites are already involved in Novo Nordisk manufacturing contracts, which are largely ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

Novo Nordisk has spared no expense in expanding its pharmaceutical reach and scope. In addition to adding new factories to ramp up production to meet demand for Ozempic and Wegovy, the company’s ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Novo Nordisk also announced plans to establish a new $800 million production facility in Denmark for tableting and packaging of oral products. That investment will create an estimated 100 new jobs.

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...